{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:06:11Z","timestamp":1792674371929,"version":"4.5.0"},"reference-count":108,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>The gut microbiota is fundamental to human health, maintaining intricate symbiotic interactions with the host. Accumulating evidence highlights a critical association between gut microbiota dysbiosis and the initiation and progression of chronic liver diseases (CLDs). Particularly hepatitis B virus (HBV)\/hepatitis C virus (HCV) infection, alcoholic liver disease (ALD), metabolic-associated steatotic liver disease (MASLD), and cirrhosis. This microbial imbalance may contribute to the progression of CLDs primarily via the \u201cgut-liver axis,\u201d the mechanisms involve gut barrier dysfunction, abnormal immune regulation, and metabolic alterations. This review synthesizes cutting-edge research on the interplay between gut dysregulation and CLDs, elaborating molecular mechanistic pathways including the TLR4\/NF-\u03baB signaling pathway, AMPK pathway, and farnesoid X receptor (FXR)-mediated bile acid signaling. Additionally, it discusses clinically oriented therapeutic strategies targeting microbiota modulation, including probiotics, fecal microbiota transplantation (FMT), and personalized dietary interventions, offering innovative insights for the prevention and management of chronic liver diseases.<\/jats:p>","DOI":"10.3389\/fmed.2026.1765047","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:58:18Z","timestamp":1769608698000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Research advances on gut microbiota dysbiosis and chronic liver diseases: a review"],"prefix":"10.3389","volume":"13","author":[{"given":"Guozhen","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Renmin Hospital of Wuhan University","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiling","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Renmin Hospital of Wuhan University","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minxin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Renmin Hospital of Wuhan University","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"She","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Renmin Hospital of Wuhan University","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Renmin Hospital of Wuhan University","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12934-020-01318-z","article-title":"Engineering probiotics as living diagnostics and therapeutics for improving human health.","volume":"19","author":"Zhou","year":"2020","journal-title":"Microb Cell Fact."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.3390\/genes14081521","article-title":"Esophageal dysbiosis in achalasia and Cancer development: a critical review.","volume":"14","author":"Tustumi","year":"2023","journal-title":"Genes."},{"key":"B3","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1556\/650.2020.31685","article-title":"[The role of intestinal macrophages and the enteric nervous system in gut neuroimmunology. basic science and clinical implications].","volume":"161","author":"D\u00f3ra","year":"2020","journal-title":"Orv Hetil."},{"key":"B4","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease.","volume":"575","author":"Duan","year":"2019","journal-title":"Nature."},{"key":"B5","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.dld.2023.06.017","article-title":"Impacts of gut microbiota alteration on age-related chronic liver diseases.","volume":"56","author":"Adhikary","year":"2024","journal-title":"Dig Liver Dis."},{"key":"B6","first-page":"V07180485","article-title":"[The gut microbiome is important in chronic liver disease].","volume":"181","author":"Christensen","year":"2019","journal-title":"Ugeskr Laeger."},{"key":"B7","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy.","volume":"66","author":"Li","year":"2014","journal-title":"Pharmacol Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"111618","DOI":"10.1016\/j.mce.2022.111618","article-title":"Discovery of farnesoid X receptor and its role in bile acid metabolism.","volume":"548","author":"Chiang","year":"2022","journal-title":"Mol Cell Endocrinol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3727\/105221618X15156018385515","article-title":"Bile acid metabolism in liver pathobiology.","volume":"18","author":"Chiang","year":"2018","journal-title":"Gene Expr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"339","DOI":"10.23736\/S2724-5985.21.02896-5","article-title":"Gut microbiota and non-alcoholic fatty liver disease.","volume":"67","author":"Abenavoli","year":"2021","journal-title":"Minerva Gastroenterol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1148\/rg.2021200168","article-title":"Human gut microbiota-associated gastrointestinal malignancies: a comprehensive review.","volume":"41","author":"Bonde","year":"2021","journal-title":"Radiographics."},{"key":"B12","doi-asserted-by":"publisher","first-page":"613120","DOI":"10.3389\/fnins.2021.613120","article-title":"Interplay of good bacteria and central nervous system: cognitive aspects and mechanistic considerations.","volume":"15","author":"Salami","year":"2021","journal-title":"Front Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"371","DOI":"10.7507\/1002-1892.202212037","article-title":"[Research progress on the relationship between gut microbiota dysbiosis and osteoarthritis].","volume":"37","author":"Jiang","year":"2023","journal-title":"Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi."},{"key":"B14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.trsl.2022.06.003","article-title":"Central and peripheral regulations mediated by short-chain fatty acids on energy homeostasis.","volume":"248","author":"Luo","year":"2022","journal-title":"Transl Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1097\/MCG.0b013e31822fecfe","article-title":"Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics.","volume":"45","author":"Macfarlane","year":"2011","journal-title":"J Clin Gastroenterol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/bs.ampbs.2023.12.001","article-title":"Microbial metabolites as modulators of host physiology.","volume":"84","author":"Joyce","year":"2024","journal-title":"Adv Microb Physiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0083421","DOI":"10.1128\/AEM.00834-21","article-title":"Integrated analyses of the gut microbiota, intestinal permeability, and serum metabolome phenotype in rats with alcohol withdrawal syndrome.","volume":"87","author":"Yang","year":"2021","journal-title":"Appl Environ Microbiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e00129-10","DOI":"10.1128\/mBio.00129-10","article-title":"Comparative analyses of the bacterial microbiota of the human nostril and oropharynx.","volume":"1","author":"Lemon","year":"2010","journal-title":"mBio."},{"key":"B19","doi-asserted-by":"publisher","first-page":"148062","DOI":"10.1016\/j.scitotenv.2021.148062","article-title":"Maternal and environmental microbes dominate offspring microbial colonization in the giant freshwater prawn Macrobrachium rosenbergii.","volume":"790","author":"Liu","year":"2021","journal-title":"Sci Total Environ."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1007\/s10482-020-01474-7","article-title":"Human gut microbiota\/microbiome in health and diseases: a review.","volume":"113","author":"Gomaa","year":"2020","journal-title":"Antonie Van Leeuwenhoek."},{"key":"B21","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3748\/wjg.v29.i1.144","article-title":"Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy via the gut-liver-brain axis.","volume":"29","author":"Luo","year":"2023","journal-title":"World J Gastroenterol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/life14050559","article-title":"Short-Chain fatty acids and human health: from metabolic pathways to current therapeutic implications.","volume":"14","author":"Facchin","year":"2024","journal-title":"Life."},{"key":"B23","doi-asserted-by":"publisher","first-page":"115276","DOI":"10.1016\/j.biopha.2023.115276","article-title":"The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: mechanisms and therapeutic potentials.","volume":"165","author":"Duan","year":"2023","journal-title":"Biomed Pharmacother."},{"key":"B24","doi-asserted-by":"publisher","first-page":"11121","DOI":"10.1021\/acs.jafc.1c04490","article-title":"Composition-Activity relationships of polysaccharides from Saccharina japonica in regulating gut microbiota in short-term high-fat diet-fed mice.","volume":"69","author":"Ke","year":"2021","journal-title":"J Agric Food Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.20517\/mrr.2023.10","article-title":"Microbial interactions and the homeostasis of the gut microbiome: the role of Bifidobacterium.","volume":"2","author":"Martin","year":"2023","journal-title":"Microbiome Res Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.3390\/microorganisms9081742","article-title":"Maternal gut dysbiosis alters offspring microbiota and social interactions.","volume":"9","author":"Zhang","year":"2021","journal-title":"Microorganisms."},{"key":"B27","doi-asserted-by":"publisher","first-page":"8421","DOI":"10.1007\/s00210-024-03204-6","article-title":"The gut-liver axis: emerging mechanisms and therapeutic approaches for nonalcoholic fatty liver disease and type 2 diabetes mellitus.","volume":"397","author":"Bhardwaj","year":"2024","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.trsl.2016.07.005","article-title":"Gut microbiome and liver disease.","volume":"179","author":"Betrapally","year":"2017","journal-title":"Transl Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1055\/s-0041-1732319","article-title":"Clinical application and progress of fecal microbiota transplantation in liver diseases: a review.","volume":"41","author":"Gu","year":"2021","journal-title":"Semin Liver Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1007\/s10620-022-07812-1","article-title":"Cystic fibrosis-related gut dysbiosis: a systematic review.","volume":"68","author":"Caley","year":"2023","journal-title":"Dig Dis Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/COH.0000000000000864","article-title":"Therapeutic microbiome modulation: new frontiers in HIV treatment.","volume":"19","author":"Bulnes","year":"2024","journal-title":"Curr Opin HIV AIDS."},{"key":"B32","doi-asserted-by":"publisher","first-page":"4183880","DOI":"10.1155\/2024\/4183880","article-title":"The role of gut microbiota modification in nonalcoholic fatty liver disease treatment strategies.","volume":"2024","author":"Yaghmaei","year":"2024","journal-title":"Int J Hepatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s12072-017-9798-x","article-title":"Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.","volume":"12","author":"Arab","year":"2018","journal-title":"Hepatol Int."},{"key":"B34","doi-asserted-by":"publisher","first-page":"7485","DOI":"10.3390\/ijms22147485","article-title":"The immune system through the lens of alcohol intake and gut microbiota.","volume":"22","author":"Calleja-Conde","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","article-title":"Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review.","volume":"19","author":"Di Vincenzo","year":"2024","journal-title":"Intern Emerg Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1136\/gutjnl-2019-318427","article-title":"Leaky gut: mechanisms, measurement and clinical implications in humans.","volume":"68","author":"Camilleri","year":"2019","journal-title":"Gut."},{"key":"B37","doi-asserted-by":"publisher","first-page":"104912","DOI":"10.1016\/j.cellimm.2024.104912","article-title":"Sodium butyrate prevents lipopolysaccharide induced inflammation and restores the expression of tight junction protein in human epithelial Caco-2 cells.","volume":"408","author":"Bakshi","year":"2025","journal-title":"Cell Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/antibiotics12101475","article-title":"Antibiotics in chronic liver disease and their effects on gut microbiota.","volume":"12","author":"Mendez-Sanchez","year":"2023","journal-title":"Antibiotics."},{"key":"B39","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3390\/medsci6030079","article-title":"Gut-Liver axis: how do gut bacteria influence the liver?","volume":"6","author":"Konturek","year":"2018","journal-title":"Med Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"100185","DOI":"10.1016\/j.ese.2022.100185","article-title":"Gut microbiota dysbiosis involves in host non-alcoholic fatty liver disease upon pyrethroid pesticide exposure.","volume":"11","author":"Li","year":"2022","journal-title":"Environ Sci Ecotechnol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.3390\/biomedicines11082108","article-title":"Steatotic liver disease: metabolic dysfunction, alcohol, or both?","volume":"11","author":"Staufer","year":"2023","journal-title":"Biomedicines."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e00037","DOI":"10.1097\/IN9.0000000000000037","article-title":"Gut microbiota and metabolite interface-mediated hepatic inflammation.","volume":"6","author":"Yang","year":"2024","journal-title":"Immunometabolism."},{"key":"B43","doi-asserted-by":"publisher","first-page":"121654","DOI":"10.1016\/j.lfs.2023.121654","article-title":"Canagliflozin attenuates thioacetamide-induced liver injury through modulation of HMGB1\/RAGE\/TLR4 signaling pathways.","volume":"322","author":"Abdelmageed","year":"2023","journal-title":"Life Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"44345","DOI":"10.1038\/s41598-025-27911-z","article-title":"Vitamin D3 attenuates hepatic inflammation in primary biliary cholangitis by inhibiting TLR4\/NF-\u03baB mediated M1 macrophage polarization.","volume":"15","author":"Wang","year":"2025","journal-title":"Sci Rep."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1007\/s13346-022-01284-6","article-title":"Short-chain fatty acid-mediated epigenetic modulation of inflammatory T cells in vitro.","volume":"13","author":"McBride","year":"2023","journal-title":"Drug Deliv Transl Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e1002983","DOI":"10.1371\/journal.ppat.1002983","article-title":"Brucella \u03b2 1,2 cyclic glucan is an activator of human and mouse dendritic cells.","volume":"8","author":"Martirosyan","year":"2012","journal-title":"PLoS Pathog."},{"key":"B47","doi-asserted-by":"publisher","first-page":"103091","DOI":"10.1016\/j.jaut.2023.103091","article-title":"Chronic inflammation in high-fat diet-fed mice: unveiling the early pathogenic connection between liver and adipose tissue.","volume":"139","author":"Bae","year":"2023","journal-title":"J Autoimmun."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.sjbs.2021.10.068","article-title":"Gut microbiota and immunity relevance in eubiosis and dysbiosis.","volume":"29","author":"Al-Rashidi","year":"2022","journal-title":"Saudi J Biol Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4103\/tcmj.tcmj_86_23","article-title":"Roles of gut microbes in metabolic-associated fatty liver disease.","volume":"35","author":"Chen","year":"2023","journal-title":"Tzu Chi Med J."},{"key":"B50","doi-asserted-by":"publisher","first-page":"117108","DOI":"10.1016\/j.foodres.2025.117108","article-title":"Lactiplantibacillus plantarum BD7807 ameliorates high-fat diet-induced lipid metabolic disorders and intestinal dysfunction via SCFAs-GPR43 pathway.","volume":"220","author":"Li","year":"2025","journal-title":"Food Res Int."},{"key":"B51","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3390\/ani9100799","article-title":"Acetate affects the process of lipid metabolism in rabbit liver. skeletal muscle and adipose tissue.","volume":"9","author":"Liu","year":"2019","journal-title":"Animals."},{"key":"B52","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3390\/metabo12070647","article-title":"Farnesoid X receptor, bile acid metabolism, and gut microbiota.","volume":"12","author":"Mori","year":"2022","journal-title":"Metabolites."},{"key":"B53","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3390\/ijms23010426","article-title":"Role of microbiota-derived metabolites in alcoholic and non-alcoholic fatty liver diseases.","volume":"23","author":"Park","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3390\/microorganisms3040759","article-title":"Gut microbiota and host reaction in liver diseases.","volume":"3","author":"Fukui","year":"2015","journal-title":"Microorganisms."},{"key":"B55","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s12072-023-10518-9","article-title":"Characteristics of microbiome-derived metabolomics according to the progression of alcoholic liver disease.","volume":"18","author":"Ganesan","year":"2024","journal-title":"Hepatol Int."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e0051821","DOI":"10.1128\/mSystems.00518-21","article-title":"Species-Level resolution of female bladder microbiota from 16S rRNA amplicon sequencing.","volume":"6","author":"Hoffman","year":"2021","journal-title":"mSystems."},{"key":"B57","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-1-4939-7015-5_3","article-title":"From gene annotation to function prediction for metagenomics.","volume":"1611","author":"Sharifi","year":"2017","journal-title":"Methods Mol Biol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e70058","DOI":"10.1002\/cph4.70058","article-title":"Metagenomic profiling of gut microbiota in kidney precision medicine project participants with CKD and AKI.","volume":"15","author":"Noel","year":"2025","journal-title":"Compr Physiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1652598","DOI":"10.3389\/fnut.2025.1652598","article-title":"The gut microbiota of Indigenous populations in the context of dietary westernization: a systematic review and meta-analysis.","volume":"12","author":"Daunizeau","year":"2025","journal-title":"Front Nutr."},{"key":"B60","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1016\/j.jhep.2020.11.013","article-title":"The microbiota in cirrhosis and its role in hepatic decompensation.","volume":"75","author":"Trebicka","year":"2021","journal-title":"J Hepatol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"557","DOI":"10.4254\/wjh.v13.i5.557","article-title":"Gut dysbiosis is associated with poorer long-term prognosis in cirrhosis.","volume":"13","author":"Maslennikov","year":"2021","journal-title":"World J Hepatol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3390\/microorganisms13051053","article-title":"Gut microbiota and the gut-liver axis in liver disease: from chronic viral hepatitis to cirrhosis, hepatocellular carcinoma, and microbiome-based therapies.","volume":"13","author":"Laivacuma","year":"2025","journal-title":"Microorganisms."},{"key":"B63","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/0023677218818605","article-title":"The role of gut microbiota in intestinal and liver diseases.","volume":"53","author":"Hrncir","year":"2019","journal-title":"Lab Anim."},{"key":"B64","doi-asserted-by":"publisher","first-page":"104167","DOI":"10.4254\/wjh.v17.i3.104167","article-title":"Gut microbiota in the development and progression of chronic liver diseases: gut microbiota-liver axis.","volume":"17","author":"Yakut","year":"2025","journal-title":"World J Hepatol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"104468","DOI":"10.1016\/j.bjid.2024.104468","article-title":"Dysregulation in the microbiota by HBV and HCV infection induces an altered cytokine profile in the pathobiome of infection.","volume":"29","author":"Padilha","year":"2025","journal-title":"Braz J Infect Dis."},{"key":"B66","doi-asserted-by":"publisher","first-page":"115072","DOI":"10.1016\/j.biopha.2023.115072","article-title":"Erythropoietin-mediated IL-17 F attenuates sepsis-induced gut microbiota dysbiosis and barrier dysfunction.","volume":"165","author":"Ling","year":"2023","journal-title":"Biomed Pharmacother."},{"key":"B67","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00253-023-12845-1","article-title":"Distinct alterations of gut microbiota between viral- and non-viral-related hepatocellular carcinoma.","volume":"108","author":"Jinato","year":"2024","journal-title":"Appl Microbiol Biotechnol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3390\/microorganisms12061110","article-title":"Changes in the gastrointestinal microbiota induced by proton pump inhibitors-a review of findings from experimental trials.","volume":"12","author":"Fossmark","year":"2024","journal-title":"Microorganisms."},{"key":"B69","doi-asserted-by":"publisher","first-page":"12000","DOI":"10.1038\/s41598-019-48352-5","article-title":"Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis.","volume":"9","author":"Horvath","year":"2019","journal-title":"Sci Rep."},{"key":"B70","doi-asserted-by":"publisher","first-page":"111912","DOI":"10.5501\/wjv.v14.i3.111912","article-title":"Gut microbiome and viral infections: a hidden nexus for immune protection.","volume":"14","author":"Gavkare","year":"2025","journal-title":"World J Virol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.3389\/fphys.2018.01671","article-title":"Chlorophyllin modulates gut microbiota and inhibits intestinal inflammation to ameliorate hepatic fibrosis in mice.","volume":"9","author":"Zheng","year":"2018","journal-title":"Front Physiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"756924","DOI":"10.3389\/fphar.2021.756924","article-title":"Phillygenin attenuates carbon tetrachloride-induced liver fibrosis via modulating inflammation and gut microbiota.","volume":"12","author":"Wang","year":"2021","journal-title":"Front Pharmacol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"121882","DOI":"10.1016\/j.lfs.2023.121882","article-title":"Gut microbiota dysbiosis and Huntington\u2019s disease: exploring the gut-brain axis and novel microbiota-based interventions.","volume":"328","author":"Sharma","year":"2023","journal-title":"Life Sci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2029674","DOI":"10.1080\/19490976.2022.2029674","article-title":"Circulating microbiome in patients with portal hypertension.","volume":"14","author":"Gedgaudas","year":"2022","journal-title":"Gut Microbes."},{"key":"B75","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.jfma.2023.09.019","article-title":"Link between gut microbiota and neonatal sepsis.","volume":"123","author":"Lee","year":"2024","journal-title":"J Formos Med Assoc."},{"key":"B76","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3390\/jcm11030890","article-title":"Effects of moderate alcohol consumption in non-alcoholic fatty liver disease.","volume":"11","author":"Lemmer","year":"2022","journal-title":"J Clin Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"e1900835","DOI":"10.1002\/mnfr.201900835","article-title":"Fat-Shaped microbiota affects lipid metabolism, liver steatosis, and intestinal homeostasis in mice fed a low-protein diet.","volume":"64","author":"Busnelli","year":"2020","journal-title":"Mol Nutr Food Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/hep.27489","article-title":"Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice.","volume":"61","author":"Chen","year":"2015","journal-title":"Hepatology."},{"key":"B79","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2147\/HMER.S371507","article-title":"Outcomes in patients with liver dysfunction post SARS-CoV-2 infection: what should we measure?","volume":"15","author":"John","year":"2023","journal-title":"Hepat Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.3390\/antiox13111386","article-title":"Gut microbiota and metabolic dysfunction-associated steatotic liver disease.","volume":"13","author":"Scarpellini","year":"2024","journal-title":"Antioxidants."},{"key":"B81","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/1751-2980.12816","article-title":"Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: a multicenter, randomized controlled trial.","volume":"20","author":"Wang","year":"2019","journal-title":"J Dig Dis."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.jhep.2020.01.017","article-title":"Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis.","volume":"72","author":"Bajaj","year":"2020","journal-title":"J Hepatol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1218552","DOI":"10.3389\/fcimb.2023.1218552","article-title":"Alterations in the gut microbiota and the efficacy of adjuvant probiotic therapy in liver cirrhosis.","volume":"13","author":"Wu","year":"2023","journal-title":"Front Cell Infect Microbiol."},{"key":"B84","first-page":"1965","article-title":"[Bacterial infections in the context of chronic liver disease].","volume":"16","author":"Perdikis","year":"2020","journal-title":"Rev Med Suisse."},{"key":"B85","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3390\/life13040991","article-title":"Gut microbiota and infectious complications in advanced chronic liver disease: focus on spontaneous bacterial peritonitis.","volume":"13","author":"Maccauro","year":"2023","journal-title":"Life."},{"key":"B86","doi-asserted-by":"publisher","first-page":"6384","DOI":"10.3390\/ijms21176384","article-title":"Co-Occurrence of hepatitis a infection and chronic liver disease.","volume":"21","author":"Kanda","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B87","doi-asserted-by":"publisher","first-page":"G42","DOI":"10.1152\/ajpgi.00017.2023","article-title":"Probiotics, prebiotics, and synbiotics in nonalcoholic fatty liver disease and alcohol-associated liver disease.","volume":"325","author":"Kaufmann","year":"2023","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1177\/0300060518776064","article-title":"Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis.","volume":"46","author":"Xia","year":"2018","journal-title":"J Int Med Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"lxad251","DOI":"10.1093\/jambio\/lxad251","article-title":"Bifidobacterium longum subsp. longum BL21 ameliorates alcoholic liver disease in mice through enhancement of the hepatic antioxidant capacity and modulation of the gut microbiota.","volume":"134","author":"Dong","year":"2023","journal-title":"J Appl Microbiol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.2217\/fmb-2017-0059","article-title":"Short-chain fatty acids: a link between prebiotics and microbiota in chronic kidney disease.","volume":"12","author":"Esgalhado","year":"2017","journal-title":"Future Microbiol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"644448","DOI":"10.3389\/fcimb.2021.644448","article-title":"Lactulose improves neurological outcomes by repressing harmful bacteria and regulating inflammatory reactions in mice after stroke.","volume":"11","author":"Yuan","year":"2021","journal-title":"Front Cell Infect Microbiol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/liv.13200","article-title":"Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy.","volume":"37","author":"Moratalla","year":"2017","journal-title":"Liver Int."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/hep.20194","article-title":"Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis.","volume":"39","author":"Liu","year":"2004","journal-title":"Hepatology."},{"key":"B94","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1007\/s10620-006-9687-y","article-title":"Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.","volume":"52","author":"Malaguarnera","year":"2007","journal-title":"Dig Dis Sci."},{"key":"B95","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/MCG.0000000000000789","article-title":"The effects of probiotics and symbiotics on risk factors for hepatic encephalopathy: a systematic review.","volume":"51","author":"Viramontes H\u00f6rner","year":"2017","journal-title":"J Clin Gastroenterol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1024678","DOI":"10.3389\/fnut.2022.1024678","article-title":"The effects of supplementation of probiotics, prebiotics, or synbiotics on patients with non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.","volume":"9","author":"Xing","year":"2022","journal-title":"Front Nutr."},{"key":"B97","doi-asserted-by":"publisher","first-page":"e1002503","DOI":"10.1371\/journal.pbio.1002503","article-title":"Fecal transplants: what is being transferred?","volume":"14","author":"Bojanova","year":"2016","journal-title":"PLoS Biol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.3390\/jcm11144119","article-title":"Fecal microbiota transplantation as new therapeutic avenue for human diseases.","volume":"11","author":"Biazzo","year":"2022","journal-title":"J Clin Med."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/hep.29306","article-title":"Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial.","volume":"66","author":"Bajaj","year":"2017","journal-title":"Hepatology."},{"key":"B100","doi-asserted-by":"publisher","first-page":"5829","DOI":"10.1097\/MS9.0000000000003649","article-title":"Fecal microbiota transplantation as a therapeutic modality for recurrent Clostridioides difficile infection: reviewing efficacy, safety, mechanisms of action, and outcomes.","volume":"87","author":"Elendu","year":"2025","journal-title":"Ann Med Surg."},{"key":"B101","doi-asserted-by":"publisher","first-page":"6326","DOI":"10.3390\/ijms22126326","article-title":"Diet-Regulating microbiota and host immune system in liver disease.","volume":"22","author":"Eom","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B102","doi-asserted-by":"publisher","first-page":"103558","DOI":"10.1016\/j.drudis.2023.103558","article-title":"Dysbiosis versus diabesity: pathological signaling and promising therapeutic strategies.","volume":"28","author":"Sharma","year":"2023","journal-title":"Drug Discov Today."},{"key":"B103","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nature12480","article-title":"Dietary intervention impact on gut microbial gene richness.","volume":"500","author":"Cotillard","year":"2013","journal-title":"Nature."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1637572","DOI":"10.3389\/fnut.2025.1637572","article-title":"MIND diet score and its association with metabolic dysfunction-associated steatotic liver disease and gut microbiota profiles: a cross-sectional study.","volume":"12","author":"Yang","year":"2025","journal-title":"Front Nutr."},{"key":"B105","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1007\/s00535-024-02121-y","article-title":"Mouse IgA modulates human gut microbiota with inflammatory bowel disease patients.","volume":"59","author":"Takahashi","year":"2024","journal-title":"J Gastroenterol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1488874","DOI":"10.3389\/fcimb.2025.1488874","article-title":"A critical review of microbiome-derived metabolic functions and translational research in liver diseases.","volume":"15","author":"Ganesan","year":"2025","journal-title":"Front Cell Infect Microbiol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3390\/biomedicines13020447","article-title":"Harnessing pharmacomultiomics for precision medicine in diabetes: a comprehensive review.","volume":"13","author":"Dhieb","year":"2025","journal-title":"Biomedicines."},{"key":"B108","doi-asserted-by":"publisher","first-page":"44085","DOI":"10.1038\/s41598-025-27783-3","article-title":"Genistein ameliorates non-alcoholic fatty liver disease in mice by modulating gut microbiota and hepatic macrophage polarization.","volume":"15","author":"Fang","year":"2025","journal-title":"Sci Rep."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1765047\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:58:23Z","timestamp":1769608703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1765047\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":108,"alternative-id":["10.3389\/fmed.2026.1765047"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1765047","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"article-number":"1765047"}}